{
    "eid": "2-s2.0-84928882692",
    "title": "CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [],
    "authors": [
        "Paola Giarda"
    ],
    "citedby-count": 2,
    "ref-count": 19,
    "ref-list": [
        "HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)",
        "Liver-related mortality in human-immunodeficiency-virusinfected patients between 1995 and 2003 in the French GERMIVIC joint study group network (MORTAVIC 2003 study)",
        "Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalit\u00e9 2005 survey, ANRS EN19)",
        "Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study: The data collection on adverse events of anti-HIV drugs (D:A:D) study group",
        "Hepatitis B and long-term HIV outcomes in coinfected HAART recipients",
        "Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-analysis",
        "Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors",
        "Hepatitis B virus infection",
        "Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues",
        "Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B",
        "High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B",
        "Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: A need for more translational study",
        "Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion",
        "Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals",
        "Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand",
        "A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients",
        "The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients",
        "Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1",
        "A vital role for Interleukin-21 in the control of a chronic viral infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kensington",
            "affilname": "The Kirby Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Monash University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Vercelli",
            "affilname": "Universit\u00e0 degli Studi del Piemonte Orientale \u201cAmedeo Avogadro\u201d",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Burnet Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Bristol-Myers Squibb",
        "Gilead Sciences",
        "National Institute of Allergy and Infectious Diseases"
    ]
}